Evidence-based follitropin.
The proper utilization of gonadotrophin during ovarian stimulation is absolutely essential and can modify the results (pregnancy rates). Moreover, several compounds and preparations are now available for use. This commentary discusses those preparations of follitropin (FbM and FbB) and the most relevant epidemiological evidence to obtain the best result during ovarian stimulation.
Cunha-Filho
Joao Sabino
JS
Human Reproduction Centre, Hospital de Clinicas de Porto Alegre, universidade Federal do Rio Grande do Sul, Brazil. sabino@via-rs.net
D019317:Evidence-Based Medicine; D005260:Female; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use*; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy; D010062:Ovulation Induction; D011247:Pregnancy; D018873:Pregnancy Rate
D006728:Hormones; D005640:Follicle Stimulating Hormone